Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar with Vinorelbine and Cisplatin in Advanced Esophageal Squamous Cell Carcinoma
NCT02665702Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Jan 2016
- Primary completion
- Sep 2018
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Fudan University. Status: unknown.
02
Drugs
endostar
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT02665702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02665702.